Neonatal Opioid Withdrawal Syndrome

The opioid crisis has grown to affect pregnant women and infants across the United States, as evidenced by rising rates of opioid use disorder among pregnant women and neonatal opioid withdrawal syndrome among infants. Across the country, pregnant women lack access to evidence-based therapies, inclu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatrics (Evanston) 2020-11, Vol.146 (5), p.e2020029074
Hauptverfasser: Patrick, Stephen W, Barfield, Wanda D, Poindexter, Brenda B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page e2020029074
container_title Pediatrics (Evanston)
container_volume 146
creator Patrick, Stephen W
Barfield, Wanda D
Poindexter, Brenda B
description The opioid crisis has grown to affect pregnant women and infants across the United States, as evidenced by rising rates of opioid use disorder among pregnant women and neonatal opioid withdrawal syndrome among infants. Across the country, pregnant women lack access to evidence-based therapies, including medications for opioid use disorder, and infants with opioid exposure frequently receive variable care. In addition, public systems, such as child welfare and early intervention, are increasingly stretched by increasing numbers of children affected by the crisis. Systematic, enduring, coordinated, and holistic approaches are needed to improve care for the mother-infant dyad. In this statement, we provide an overview of the effect of the opioid crisis on the mother-infant dyad and provide recommendations for management of the infant with opioid exposure, including clinical presentation, assessment, treatment, and discharge.
doi_str_mv 10.1542/peds.2020-029074
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2467629535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2467629535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-53d99764c7245cbf5515102e0676d2d663fbd95aee23b21967e9e5d249de44a3</originalsourceid><addsrcrecordid>eNo9kM9LAzEQhYModq3ePUmh562TSSYxRyn-gmIPFjyG7CaLW7rdNdki_e_d0upp4PHeN_AxdsthxknifRd8miEg5IAGtDxjGQfzkEvUdM4yAMFzCUAjdpXSGgAkabxkIyE4KCF5xqbvod263m0my65uaz_5rPsvH93PkHzstz62TbhmF5XbpHBzumO2en5azV_zxfLlbf64yEuhTJ-T8MZoJUuNksqiIuLEAQMorTx6pURVeEMuBBQFcqN0MIE8SuODlE6M2fSI7WL7vQupt-t2F7fDR4tyYKAhQUMLjq0ytinFUNku1o2Le8vBHqTYgxR7kGKPUobJ3Qm8K5rg_wd_FsQvOX5bOg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2467629535</pqid></control><display><type>article</type><title>Neonatal Opioid Withdrawal Syndrome</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Patrick, Stephen W ; Barfield, Wanda D ; Poindexter, Brenda B</creator><creatorcontrib>Patrick, Stephen W ; Barfield, Wanda D ; Poindexter, Brenda B ; COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION</creatorcontrib><description>The opioid crisis has grown to affect pregnant women and infants across the United States, as evidenced by rising rates of opioid use disorder among pregnant women and neonatal opioid withdrawal syndrome among infants. Across the country, pregnant women lack access to evidence-based therapies, including medications for opioid use disorder, and infants with opioid exposure frequently receive variable care. In addition, public systems, such as child welfare and early intervention, are increasingly stretched by increasing numbers of children affected by the crisis. Systematic, enduring, coordinated, and holistic approaches are needed to improve care for the mother-infant dyad. In this statement, we provide an overview of the effect of the opioid crisis on the mother-infant dyad and provide recommendations for management of the infant with opioid exposure, including clinical presentation, assessment, treatment, and discharge.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.2020-029074</identifier><identifier>PMID: 33106341</identifier><language>eng</language><publisher>United States: American Academy of Pediatrics</publisher><subject>Babies ; Drug addiction ; Drug withdrawal ; Female ; Humans ; Infant, Newborn ; Infants ; Mass Screening ; Narcotics ; Neonatal abstinence syndrome ; Neonatal Abstinence Syndrome - diagnosis ; Neonatal Abstinence Syndrome - therapy ; Neonates ; Newborn babies ; Opioid-Related Disorders - diagnosis ; Opioid-Related Disorders - therapy ; Opioids ; Pediatrics ; Practice Guidelines as Topic ; Pregnancy ; Pregnancy Complications - diagnosis ; Pregnancy Complications - therapy ; United States</subject><ispartof>Pediatrics (Evanston), 2020-11, Vol.146 (5), p.e2020029074</ispartof><rights>Copyright © 2020 by the American Academy of Pediatrics.</rights><rights>Copyright American Academy of Pediatrics Nov 1, 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-53d99764c7245cbf5515102e0676d2d663fbd95aee23b21967e9e5d249de44a3</citedby><cites>FETCH-LOGICAL-c369t-53d99764c7245cbf5515102e0676d2d663fbd95aee23b21967e9e5d249de44a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33106341$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Patrick, Stephen W</creatorcontrib><creatorcontrib>Barfield, Wanda D</creatorcontrib><creatorcontrib>Poindexter, Brenda B</creatorcontrib><creatorcontrib>COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION</creatorcontrib><title>Neonatal Opioid Withdrawal Syndrome</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>The opioid crisis has grown to affect pregnant women and infants across the United States, as evidenced by rising rates of opioid use disorder among pregnant women and neonatal opioid withdrawal syndrome among infants. Across the country, pregnant women lack access to evidence-based therapies, including medications for opioid use disorder, and infants with opioid exposure frequently receive variable care. In addition, public systems, such as child welfare and early intervention, are increasingly stretched by increasing numbers of children affected by the crisis. Systematic, enduring, coordinated, and holistic approaches are needed to improve care for the mother-infant dyad. In this statement, we provide an overview of the effect of the opioid crisis on the mother-infant dyad and provide recommendations for management of the infant with opioid exposure, including clinical presentation, assessment, treatment, and discharge.</description><subject>Babies</subject><subject>Drug addiction</subject><subject>Drug withdrawal</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infants</subject><subject>Mass Screening</subject><subject>Narcotics</subject><subject>Neonatal abstinence syndrome</subject><subject>Neonatal Abstinence Syndrome - diagnosis</subject><subject>Neonatal Abstinence Syndrome - therapy</subject><subject>Neonates</subject><subject>Newborn babies</subject><subject>Opioid-Related Disorders - diagnosis</subject><subject>Opioid-Related Disorders - therapy</subject><subject>Opioids</subject><subject>Pediatrics</subject><subject>Practice Guidelines as Topic</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - diagnosis</subject><subject>Pregnancy Complications - therapy</subject><subject>United States</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM9LAzEQhYModq3ePUmh562TSSYxRyn-gmIPFjyG7CaLW7rdNdki_e_d0upp4PHeN_AxdsthxknifRd8miEg5IAGtDxjGQfzkEvUdM4yAMFzCUAjdpXSGgAkabxkIyE4KCF5xqbvod263m0my65uaz_5rPsvH93PkHzstz62TbhmF5XbpHBzumO2en5azV_zxfLlbf64yEuhTJ-T8MZoJUuNksqiIuLEAQMorTx6pURVeEMuBBQFcqN0MIE8SuODlE6M2fSI7WL7vQupt-t2F7fDR4tyYKAhQUMLjq0ytinFUNku1o2Le8vBHqTYgxR7kGKPUobJ3Qm8K5rg_wd_FsQvOX5bOg</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Patrick, Stephen W</creator><creator>Barfield, Wanda D</creator><creator>Poindexter, Brenda B</creator><general>American Academy of Pediatrics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope></search><sort><creationdate>202011</creationdate><title>Neonatal Opioid Withdrawal Syndrome</title><author>Patrick, Stephen W ; Barfield, Wanda D ; Poindexter, Brenda B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-53d99764c7245cbf5515102e0676d2d663fbd95aee23b21967e9e5d249de44a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Babies</topic><topic>Drug addiction</topic><topic>Drug withdrawal</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infants</topic><topic>Mass Screening</topic><topic>Narcotics</topic><topic>Neonatal abstinence syndrome</topic><topic>Neonatal Abstinence Syndrome - diagnosis</topic><topic>Neonatal Abstinence Syndrome - therapy</topic><topic>Neonates</topic><topic>Newborn babies</topic><topic>Opioid-Related Disorders - diagnosis</topic><topic>Opioid-Related Disorders - therapy</topic><topic>Opioids</topic><topic>Pediatrics</topic><topic>Practice Guidelines as Topic</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - diagnosis</topic><topic>Pregnancy Complications - therapy</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patrick, Stephen W</creatorcontrib><creatorcontrib>Barfield, Wanda D</creatorcontrib><creatorcontrib>Poindexter, Brenda B</creatorcontrib><creatorcontrib>COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patrick, Stephen W</au><au>Barfield, Wanda D</au><au>Poindexter, Brenda B</au><aucorp>COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neonatal Opioid Withdrawal Syndrome</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>2020-11</date><risdate>2020</risdate><volume>146</volume><issue>5</issue><spage>e2020029074</spage><pages>e2020029074-</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><abstract>The opioid crisis has grown to affect pregnant women and infants across the United States, as evidenced by rising rates of opioid use disorder among pregnant women and neonatal opioid withdrawal syndrome among infants. Across the country, pregnant women lack access to evidence-based therapies, including medications for opioid use disorder, and infants with opioid exposure frequently receive variable care. In addition, public systems, such as child welfare and early intervention, are increasingly stretched by increasing numbers of children affected by the crisis. Systematic, enduring, coordinated, and holistic approaches are needed to improve care for the mother-infant dyad. In this statement, we provide an overview of the effect of the opioid crisis on the mother-infant dyad and provide recommendations for management of the infant with opioid exposure, including clinical presentation, assessment, treatment, and discharge.</abstract><cop>United States</cop><pub>American Academy of Pediatrics</pub><pmid>33106341</pmid><doi>10.1542/peds.2020-029074</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0031-4005
ispartof Pediatrics (Evanston), 2020-11, Vol.146 (5), p.e2020029074
issn 0031-4005
1098-4275
language eng
recordid cdi_proquest_journals_2467629535
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Babies
Drug addiction
Drug withdrawal
Female
Humans
Infant, Newborn
Infants
Mass Screening
Narcotics
Neonatal abstinence syndrome
Neonatal Abstinence Syndrome - diagnosis
Neonatal Abstinence Syndrome - therapy
Neonates
Newborn babies
Opioid-Related Disorders - diagnosis
Opioid-Related Disorders - therapy
Opioids
Pediatrics
Practice Guidelines as Topic
Pregnancy
Pregnancy Complications - diagnosis
Pregnancy Complications - therapy
United States
title Neonatal Opioid Withdrawal Syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T23%3A49%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neonatal%20Opioid%20Withdrawal%20Syndrome&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Patrick,%20Stephen%20W&rft.aucorp=COMMITTEE%20ON%20FETUS%20AND%20NEWBORN,%20COMMITTEE%20ON%20SUBSTANCE%20USE%20AND%20PREVENTION&rft.date=2020-11&rft.volume=146&rft.issue=5&rft.spage=e2020029074&rft.pages=e2020029074-&rft.issn=0031-4005&rft.eissn=1098-4275&rft_id=info:doi/10.1542/peds.2020-029074&rft_dat=%3Cproquest_cross%3E2467629535%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2467629535&rft_id=info:pmid/33106341&rfr_iscdi=true